New collaboration will integrate Propeller’s platform with UC Davis Health’s electronic health record system to efficiently provide clinicians data on patient’s disease management
(SACRAMENTO, Calif.) — UC Davis Health and Propeller Health have announced a new collaboration that will offer personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease (COPD) aiming to improve their health outcomes.
As part of the collaboration, UC Davis Health will provide the Propeller program – including sensors, mobile app, web portal, and personalized support – to eligible patients, with eventual expansion to patients in other UC locations and UC affiliates. The sensors attach to a patient’s inhaler to capture unique signals that record events, such as medication usage or respiration. This data will be transmitted directly to UC Davis Health’s Epic® electronic health record (EHR) system to support patient enrollment and remote patient monitoring via single sign-on.
It's no secret that health systems are feeling strained, with 47% of physicians experiencing symptoms of clinician burnout.1 An overwhelming amount of clinical data, jam-packed days with little time to connect with patients, and a lengthy list of responsibilities are leaving healthcare professionals feeling drained.
Clinician exhaustion can lead to reduced job satisfaction, increased turnover, and a decrease in the quality of care provided to patients. But burnout isn’t only harmful to teams — it can also cause financial strain on health systems. According to a study by the Annals of Internal Medicine, clinician exhaustion accumulates approximately $4.6 billion in costs due to turnover and reduced clinic hours.2
But when health systems use digital tools the right way, they can reduce the risk of clinician burnout and increase patient care coordination.
Today marks an incredible milestone: Propeller Health's 13th birthday. What began as a quest to solve a public health problem has turned into a global precision digital health company driving meaningful, measurable change in the industry.
Recognizing early on that creating value for all parties in health – health systems, clinicians, payers, and pharmaceutical companies – is essential in order to drive sustainable change, we’ve spent the past 13 years pioneering innovative solutions that always keep the patient at the center. Our story is one of hard work, dedication, collaboration, and above all, a mission to uplift every person living with a chronic disease so they can breathe easier, stay healthier, and live better lives.
Propeller was founded on the heels of a then-mysterious string of asthma attacks in Barcelona in the 1980s. It took 8 years for experts to identify soybean dust – not yet recognized as an allergen – as the trigger. One CDC disease detective envisioned a better way to monitor public health: by using technology to track medication usage and symptoms. With this mission, Propeller was born.
The American Academy of Allergy, Asthma and Immunology (AAAAI) has accepted five abstracts examining the latest data from Propeller Health and ResMed.
Our findings on asthma care, which include analyzing the direct and indirect cost-savings associated with a digital intervention in uncontrolled asthma, will be presented at the AAAAI Annual Meeting on February 24-27. Read brief summaries of each abstract below or click the links to view them online.
Direct and indirect cost-savings associated with a digital intervention in uncontrolled asthma: A literature-based estimate
At J.P. Morgan’s 41st annual healthcare conference, there was no shortage of innovative discussions. We’ve rounded up some of the biggest themes from this year’s conference:
Connected drug delivery devices are gaining traction among top pharma companies
As medication non-adherence continues to plague the global life sciences industry – more than $600 billion in annual revenue is lost1 – many pharmaceutical companies are evaluating new approaches to improving patient engagement, including embedded sensors that capture data through drug delivery devices. One of the biggest selling points for organizations is that connected drug delivery devices can play a huge role in boosting adherence and compliance. Devices that can detect and capture data around patient-administered therapy, such as dose timing, volume, and technique, have become an increasingly popular choice among leading organizations. Patients are more likely to refill and take their medications on time, and correctly, if they can be prompted to do so and have a record of dosing history.
With perpetually rising healthcare costs, soaring operating expenses, and plummeting profit margins, health systems are pressured to re-evaluate their care delivery models and shift their focus to value.
Implementing the right tools to enhance decision making and build care management capabilities for population health, risk stratification, and site-of-care optimization will be vital for navigating this actively evolving landscape. Digital health solutions are critical enablers of success, especially having demonstrated clinical and real-world outcomes in all reimbursement settings.
In an outcomes-based payment model, health systems can leverage digital solutions to:
A staggering 97% of medical practices experienced a negative financial impact at the beginning of the pandemic, including a 60% decrease in patient volume and a 55% decline in revenue.1 Nearly three years later, more than half of hospitals are still experiencing negative margins.2
To ensure success in this actively evolving landscape, health systems must equip themselves with the right tools to enhance decision making and reduce administrative burden through frictionless clinician experiences. Digital health solutions are critical enablers of success, especially having demonstrated clinical and real-world outcomes in all reimbursement settings.
In a traditional payment model, digital solutions can help health systems:
Health systems faced major headwinds in 2022: ongoing clinician burnout, soaring staffing shortages, and plummeting financial margins. Fortunately, the healthcare industry has been actively restructuring its landscape and building new momentum in reimbursement, value-based care, and patient engagement. With all the fundamental shifts to come in 2023, health systems have the most to gain… and the most to lose if they don’t take prompt action.
Here are the most pressing changes health systems can expect – and should immediately prepare for:
New CMS rulemaking on remote therapeutic monitoring is more practical for health systems
More than 90,000 new digital health solutions entered the market in 2020,1 and annual growth is expected to increase 27% over the next 8 years.2 For health systems, this creates an unprecedented opportunity to leverage digital solutions, especially considering: expanded reimbursement opportunities for remote monitoring, soaring patient engagement, and increased physician demand.
With so many digital options available, comprehensive partner evaluations are critical for identifying solutions with staying power, ensuring successful implementation, and developing the necessary infrastructure to support integration at scale. If health systems aren’t asking the right questions during their value assessments, they won’t see a return on their investments.
These are the top 5 questions health systems must consider before heading into their digital partner evaluations: